You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 8, 2025

CLINICAL TRIALS PROFILE FOR ENSPRYNG

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for ENSPRYNG

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT04660539 ↗	A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)	Active, not recruiting	Hoffmann-La Roche	Phase 3	2021-03-02	This multicenter, single-arm, open-label study will evaluate the long-term safety and efficacy of satralizumab in patrticipants with neuromyelitis optica spectrum disorder (NMOSD) who completed open-label extension (OLE) period of studies BN40898 and BN40900. Participants will receive satralizumab as monotherapy or in combination with one of the following background immunosuppressive treatments: azathioprine (AZA), mycophenolate mofetil (MMF), or oral corticosteroids.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ENSPRYNG

Condition Name

Chart
Table

Condition Name for ENSPRYNG
Intervention	Trials
Neuromyelitis Optica Spectrum Disorder	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ENSPRYNG
Intervention	Trials
Neuromyelitis Optica	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ENSPRYNG

Trials by Country

Map
Table

Trials by Country for ENSPRYNG
Location	Trials
United States	10
Ukraine	4
Italy	2
Canada	2
Korea, Republic of	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for ENSPRYNG
Location	Trials
Texas	1
Pennsylvania	1
Ohio	1
North Carolina	1
Michigan	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ENSPRYNG

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ENSPRYNG
Clinical Trial Phase	Trials
Phase 3	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ENSPRYNG
Clinical Trial Phase	Trials
Active, not recruiting	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ENSPRYNG

Sponsor Name

Chart
Table

Sponsor Name for ENSPRYNG
Sponsor	Trials
Hoffmann-La Roche	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ENSPRYNG
Sponsor	Trials
Industry	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.